Breast cancer
Results
Phase 3
This trial looked at whether zoledronic acid helps to stop breast cancer coming back.
This trial was supported by Cancer Research UK.
Recruitment start: 1 September 2003
Recruitment end: 16 February 2006
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Coleman
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Novartis
Sheffield University
This is Cancer Research UK trial number CRUKE/03/017.
Last reviewed: 18 August 2014
CRUK internal database number: 258